$EPC

EDGEWELL PERSONAL CARE Co (EPC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 17, 2026, Edgewell Personal Care Company (the “Company”) determined that LaTanya Langley will serve as the Com

Original reporting
Published Sep 23, 2026, 12:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 12:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$EPC
Neutral
high confidence
Mentioned
$EPC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EPCNeutralLow
01

Why it matters

The filing is a routine corporate governance update with no material financial impact.

02

Market read

Minor relevance; primarily of interest to shareholders monitoring executive changes.

03

What to watch

Potential future changes in legal or administrative strategy.

Relevance 6/10Novelty 5/10Timing: effective Oct 1 2026

Background

Edgewell Personal Care Co filed an 8‑K announcing an internal officer reassignment.

Company-level read

Ticker impact

$EPCNeutralHigh confidence
Context

SEC Form 8‑K reports LaTanya Langley's new role as Chief Administrative and Legal Officer and Corporate Secretary effective Oct 1 2026.

Expected impact

little to no short‑term movement

Evidence & confidence

The filing is a routine executive transition with no compensation change or strategic shift disclosed.

Market effects

None significant for the personal care sector.

U.S. market only; no broader regional effect.

Limited to Edgewell investors.

Counterpoint

The appointment could signal upcoming restructuring not yet disclosed.

Key entities

  • Edgewell Personal Care Co

    U.S. personal care products manufacturer (ticker EPC).

  • LaTanya Langley

    Appointed Chief Administrative and Legal Officer and Corporate Secretary.

Related articles

$EPCMed

Edgewell’s (EPC) Margins Slip Even As North America Rebounds

Edgewell Personal Care (EPC) reported Q3 2026 results with net sales up 1.7% to $570.1M, driven by North America's 3.0% organic growth. However, operating income fell 44% due to margin declines and higher costs. Adjusted EPS held at $0.72, matching prior year. CEO Rod Little called it an 'important step forward.'

$EPCMed

How Edgewell’s Revenue Miss and Margin Pressure Will Impact Edgewell Personal Care (EPC) Investors

Edgewell Personal Care (EPC) reported Q2 revenue up 1.7% YoY but missed estimates, with organic revenue and EBITDA also below forecasts. Management highlighted adjusted EPS and EBITDA beating expectations, but weaker margins and EPS momentum raised concerns. The company affirmed its dividend while lowering full-year EPS guidance, focusing on cash generation amid profitability scrutiny. Analysts project $2.0B revenue and $769.1M earnings by 2029, with a 11% upside to current price.

$EPCMedAI 8/10

Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% reported and 1.1% organic, with North America organic growth of 3.0% and international down 1.4% due to Middle East and supply disruptions. Adjusted EPS was $0.72. Full-year guidance: organic net sales flat to 0.5%, adjusted EPS $1.80-$2.00, EBITDA $250-$260 million.

$EPCMedAI 8/10

Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% on a 1.1% organic increase. Adjusted EPS was $0.72, flat year over year. Adjusted EBITDA fell to $78.9 million. Management cited North America organic growth of 3.0% and a 1.4% international decline from Middle East and supply disruptions. Full-year organic sales guidance is flat to +0.5%, adjusted EPS $1.80-$2.00.